Hebei Province starts the withdrawal mechanism of low price drug list

Source: on May 27, 2015, the price bureau of Hebei Province issued a notice on its official website, and began to accept the application of enterprises to withdraw from the current national and provincial low-cost drug list This means that the withdrawal mechanism of low-cost drug list in Hebei Province has been launched, and further in drug price reform, especially in improving the price management of low-cost drugs Low cost drugs refer to the drugs with low daily average cost within the current government guidance price range ("daily average cost" refers to the total cost of one day dosage of a drug taken by patients) At present, the average daily cost of low-cost drugs in China is no more than 3 yuan for western medicine and no more than 5 yuan for Chinese patent medicine In recent years, the problems of low-cost drugs are increasingly prominent People feel that many drugs with low price and obvious curative effect are not easy to buy Hospitals do not sell them and pharmacies are hard to find Driven by profits, more and more low-cost drugs are replaced by high-cost drugs with new names In order to supply commonly used low-cost drugs and protect the rights and interests of patients, the national development and Reform Commission issued a notice in April last year, asking to improve the price management mode of low-cost drugs, remove the maximum retail price limit for 533 kinds of low-cost drugs within the current government guidance price range, and make the purchase and sale price independently within the daily average cost standard At the same time, all provinces (districts and cities) are required to publish the list of low-cost drugs to the public, and establish the entry and exit mechanism of the list of low-cost drugs Subsequently, the national development and Reform Commission released the "national version" list of low-cost drugs, which covers 533 kinds of low-cost drugs On this basis, Hebei Province released a list of 241 low-cost drugs belonging to the province in July last year, of which the daily low-cost drugs accounted for the majority, such as vitamin A, vitamin C Yinqiao Tablets, Compound Ganmaoling granules, Huoxiang Zhengqi pill, Xiaoer Qingre Zhike oral liquid, etc According to the requirements of the national development and Reform Commission, while establishing the list of low-cost drugs, it is necessary to establish the entry and exit mechanism of the list If the daily average cost meets the low-cost drug standard due to the change of price, usage and dosage, it will be included in the low-cost drug list in time If the daily average cost exceeds the low price drug standard due to the increase of production cost or the change of usage and dosage, the low price drug list shall be withdrawn in time According to the staff of the provincial Price Bureau, at present, Hebei Province has begun to accept the application of enterprises intending to withdraw from the current national and provincial list of low-cost drugs, which means that Hebei Province has made further progress in drug price reform, especially in improving the price management of low-cost drugs.